Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a9532d9dc13d720a47ea143",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tolperisone Hydrochloride Sustained Release Tablets 450 mg",
"description": "**Tolperisone hydrochloride** is a centrally acting muscle relaxant used to help reduce excessive muscle tone, stiffness, and muscle spasms associated with certain musculoskeletal and neurological conditions. Compared with some other centrally acting muscle relaxants, tolperisone is generally considered to have relatively limited sedative effects, although individual responses can vary.\n\n**TOPERITME 450** is formulated as a sustained-release tablet. This formulation is designed to release the active ingredient gradually, helping maintain its therapeutic effect over the prescribed dosing period.\n\nWhat TOPERITME 450 May Be Used For\n\nA healthcare professional may prescribe **TOPERITME 450** for conditions involving painful muscle tightness or spasms, including:\n\n* Painful muscle spasms\n* Selected musculoskeletal disorders\n* Neck and shoulder muscle stiffness\n* Lower back discomfort associated with muscle spasm\n* Cervical or lumbar spondylosis accompanied by muscle tightness\n* Muscle spasms associated with injury or trauma\n* Increased muscle tone associated with certain neurological conditions, when clinically appropriate\n\nThe decision to use tolperisone should be based on the patient's symptoms, diagnosis, and medical assessment.\n\nWhy TOPERITME 450 May Be Preferred\n\nTOPERITME 450 may offer several practical advantages when prescribed appropriately:\n\n* Sustained-release formulation for gradual drug delivery\n* Helps reduce muscle spasms and excessive muscle tension\n* May support improved movement when muscle stiffness is limiting mobility\n* Can help relieve discomfort associated with tight muscles\n* Convenient oral tablet formulation\n* Intended for use according to an individualized medical treatment plan\n\nPatients should always follow the dosage and duration recommended by their healthcare provider.\n\nMechanism of Action\n\n**Tolperisone hydrochloride** acts primarily through the central nervous system to reduce abnormal or excessive muscle activity. By modulating nerve signals involved in muscle tone and reflex activity, it can help decrease muscle stiffness and spasms.\n\nThe sustained-release formulation of **TOPERITME 450** is designed to release tolperisone progressively rather than all at once. This provides controlled delivery throughout the prescribed dosing interval.\n\n Dosage and Administration\n\nThe appropriate dose of **TOPERITME 450** should be determined by a qualified healthcare professional according to the patient's condition and treatment requirements.\n\nImportant administration instructions include:\n\n* Take the medicine exactly as prescribed.\n* Swallow the tablet whole with water.\n* Do not crush, chew, or split the sustained-release tablet unless specifically instructed by your doctor.\n* Maintain the prescribed dosing schedule.\n* If you forget a dose, seek guidance from your healthcare provider rather than taking an extra dose independently.\n\n Possible Side Effects\n\nSome individuals may experience side effects while taking **TOPERITME 450**. Potential reactions include:\n\n* Nausea\n* Dizziness\n* Headache\n* Weakness\n* Stomach discomfort\n* Allergic reactions\n\nNot everyone experiences side effects, and their severity can differ between individuals.\n\nIf serious allergic symptoms such as facial or throat swelling, breathing difficulty, or a severe unusual reaction occur, seek immediate medical attention.\n\nPrecautions to Discuss With Your Doctor\n\nBefore starting **TOPERITME 450**, inform your healthcare professional if you have:\n\n* Liver disease\n* Kidney disease\n* A previous history of drug allergies\n* Pregnancy or plans to become pregnant\n* Breastfeeding\n* Any other ongoing medical condition\n* Current use of prescription or over-the-counter medicines\n\nProviding a complete medication history can help your healthcare provider assess potential interactions and determine whether tolperisone is appropriate.\n\n Storage Guidelines\n\nFor proper storage of **TOPERITME 450**:\n\n* Keep the medicine in a cool and dry place.\n* Protect it from excessive moisture.\n* Keep the tablets away from direct sunlight.\n* Store according to the temperature instructions printed on the packaging.\n* Keep the medicine out of children's reach.\n* Do not use tablets after their stated expiry date.\n\nWhy Choose TOPERITME 450?\n\n**TOPERITME 450** contains tolperisone hydrochloride in a sustained-release formulation intended to provide controlled drug delivery. It may be selected by healthcare professionals for suitable patients experiencing muscle spasms, increased muscle tone, or stiffness associated with certain musculoskeletal conditions.\n\nTreatment should be individualized, and the medicine should be taken only according to professional medical advice.\n\n Frequently Asked Questions\n\nWhat is TOPERITME 450 prescribed for?\n\nTOPERITME 450 may be prescribed to help manage painful muscle spasms, stiffness, and increased muscle tone associated with selected musculoskeletal or neurological conditions.\n\nHow should I take TOPERITME 450?\n\nTake TOPERITME 450 exactly as prescribed and swallow the sustained-release tablet whole with water. Do not crush or chew it unless your healthcare professional specifically instructs you to do so.\n\nCan I stop TOPERITME 450 when my symptoms improve?\n\nDo not discontinue or modify your treatment without consulting your healthcare provider. The recommended treatment duration depends on your condition and individual response.\n\nIs TOPERITME 450 safe during pregnancy?\n\nUse during pregnancy should only be considered after consultation with a qualified healthcare professional, who can assess the potential benefits and risks for the individual patient.\n\nCan TOPERITME 450 cause drowsiness?\n\nSome individuals may experience dizziness or drowsiness, while others may not. If you experience impaired alertness, avoid driving or operating machinery until you know how the medicine affects you.",
"price": 530.0,
"discountamount": 159.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2500,
"imageuri": "https://productimages.withfloats.com/actual/6a9532dd5c122cfb47f3b8bb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a9532dd5c122cfb47f3b8bb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-31T07:52:57.389Z",
"updatedon": "2026-08-31T07:52:57.389Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-sustained-release-tablets-450-mg/2500",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TOPERITIME 450",
"category": "ORTHOPEDICS RANGE",
"tags": [
"Tolperisone Hydrochloride Sustained Release Tablets 450 mg",
"tolperisone hydrochloride uses",
"tolperisone hydrochloride",
"tolperisone hydrochloride use"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a952f8fed078617ad2e762a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Palmitoylethanolamide,Parsley Extract & Multivitamin Tablets",
"description": "What Are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets?\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets are a combination of nutritional supplements formulated with **palmitoylethanolamide (PEA), parsley extract, vitamins, and minerals**. The precise ingredients and quantities can differ between products, so the product label should always be checked for the exact composition and recommended serving.\n\nEach component has a different nutritional or biological role. **Palmitoylethanolamide (PEA)** is a naturally occurring fatty-acid amide that has been researched for its potential contribution to pain-related and inflammatory processes. Clinical research has shown particular interest in PEA for pain-management outcomes, especially when specific formulations such as micronized or ultramicronized PEA are used.\n\n**Parsley extract**, obtained from *Petroselinum crispum*, contains naturally occurring plant compounds, including flavonoids and phenolic constituents. Research has identified compounds such as apigenin and apiin in parsley and has demonstrated antioxidant activity in experimental settings. However, laboratory antioxidant activity should not be interpreted as proof that parsley extract prevents or treats a particular disease.\n\nThe multivitamin component supplies selected vitamins and minerals that contribute to normal nutritional requirements. Such supplements can be useful when dietary intake does not provide adequate amounts of particular nutrients, but they are intended to complement rather than replace a balanced diet.\n\nHow Do Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets Work?\n\nThe combination works through the individual characteristics of its principal ingredients rather than through a single mechanism.\n\n1. Palmitoylethanolamide\n\nPalmitoylethanolamide (PEA) is an endogenous lipid compound found naturally in the body. It has been investigated for its potential analgesic, anti-inflammatory, and neuroprotective activities.\n\nClinical research has examined PEA in various pain-related and neurological settings. Evidence from randomized controlled trials has been particularly promising for pain-related outcomes. However, different PEA products can contain different formulations, and results from one preparation should not automatically be applied to every PEA supplement.\n\n 2. Parsley Extract\n\nParsley contains several naturally occurring phytochemicals, including flavonoids and phenolic compounds. These substances have demonstrated antioxidant properties in experimental research.\n\nThe presence of parsley extract therefore adds a plant-derived nutritional component to the formulation. However, human evidence remains more limited than laboratory research, so claims about disease prevention or treatment should be avoided unless supported by appropriate clinical evidence.\n\n3. Vitamins and Minerals\n\nThe multivitamin portion is designed to provide selected micronutrients that contribute to normal body functions. Vitamins and minerals participate in numerous physiological processes, including energy metabolism, immune function, nervous-system function, and maintenance of tissues.\n\nThe actual nutritional contribution depends on which vitamins and minerals are included and their quantities per tablet or serving.\n\nPotential Benefits of Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets\n\nThe potential benefits of this combination depend on its exact formulation and the nutritional requirements of the individual.\n\nSupport for Pain-Management Strategies\n\nPEA is the component in this combination with the most relevant clinical research. Studies have evaluated PEA as a complementary nutritional approach in different pain conditions, with evidence showing particular interest in pain-related outcomes.\n\nHowever, the presence of PEA does not mean that every PEA-containing supplement is clinically proven to treat chronic pain, neuropathy, or other medical disorders.\n\nNutritional Support\n\nThe vitamin and mineral component can help increase nutrient intake when normal dietary consumption is inadequate.\n\nPeople with restricted diets, reduced food intake, or specific nutritional gaps may sometimes benefit from supplementation. However, supplements are not intended to replace a varied and nutritionally balanced diet.\n\nAntioxidant Nutritional Support\n\nParsley provides naturally occurring flavonoids and phenolic compounds that demonstrate antioxidant activity in experimental research.\n\nThese properties make parsley an interesting botanical ingredient in nutritional formulations, although laboratory findings do not necessarily establish a specific clinical benefit in humans.\n\nConvenient Combination Formula\n\nA combination tablet can offer convenience by bringing PEA, parsley extract, vitamins, and minerals together in one formulation.\n\nConsumers should focus on the actual quantities provided per tablet rather than simply the number of ingredients listed on the packaging.\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets: Uses\n\nDepending on the specific product formulation and labeling, these tablets may be used as a nutritional supplement to\n\n* Support daily nutritional intake\n* Provide selected vitamins and minerals\n* Supply palmitoylethanolamide as part of a complementary wellness or pain-management approach\n* Provide naturally occurring compounds from parsley extract\n* Complement overall nutritional and antioxidant intake\n\nThese supplements should not be promoted as guaranteed treatments or cures for neuropathy, arthritis, inflammation, nerve injury, or other medical diseases.\n\n How to Select the Right Product\n\n 1. Check the PEA Quantity\n\nReview the label to determine the actual amount of **palmitoylethanolamide per tablet or daily serving**.\n\n 2. Consider the PEA Formulation\n\nDifferent clinical studies have evaluated different PEA preparations. Micronized, ultramicronized, and water-dispersible forms have received particular attention in clinical research.\n\n3. Review the Vitamin and Mineral Profile\n\nExamine the complete nutritional panel rather than assuming all multivitamin formulations contain the same nutrients and quantities.\n\n4. Avoid Nutrient Duplication\n\nIf you already use a multivitamin or individual supplements containing nutrients such as vitamin A, iron, zinc, or other minerals, compare the total daily intake to avoid unnecessary excess.\n\n 5. Check Product Information\n\nLook for transparent labeling, manufacturer details, batch information, expiry information, and appropriate quality-control details.\n\n 6. Choose According to Individual Requirements\n\nA product containing more ingredients or higher quantities is not necessarily more beneficial. Selection should be based on individual nutritional requirements and professional guidance when necessary.\n\nPossible Side Effects and Safety\n\nDietary supplements are generally well tolerated when appropriately formulated and used according to directions, but adverse effects and interactions can occur.\n\nPossible problems may include:\n\n* Nausea\n* Stomach discomfort\n* Changes in bowel habits\n* Headache\n* Sensitivity or allergic reactions to individual ingredients\n* Excessive intake of particular vitamins or minerals\n\nThe exact safety profile depends on the complete ingredient list and quantities in the individual product.\n\nPeople who take prescription medicines, have significant medical conditions, are pregnant or breastfeeding, or are preparing for surgery should discuss supplementation with a qualified healthcare professional.\n\nWho Should Use Extra Caution?\n\nAdditional care may be appropriate for individuals who:\n\n* Take several nutritional supplements\n* Regularly use prescription medicines\n* Have an existing medical condition\n* Are pregnant or breastfeeding\n* Have an allergy or sensitivity to an ingredient\n* Are preparing for surgery\n* Are considering supplementation for persistent or unexplained pain\n\nMultivitamins should also not be used as a substitute for a consistently varied diet.\n\nFrequently Asked Questions\n\n1. What are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets used for?\n\nThey are combination nutritional supplements containing PEA, parsley extract, vitamins, and minerals. Depending on the formulation, they may provide nutritional support and PEA as a complementary component of a wellness or pain-management approach.\n\n2. What are the main benefits of these tablets?\n\nPotential benefits depend on the formulation. PEA has been clinically studied mainly for pain-related outcomes; parsley provides naturally occurring plant compounds; and vitamins and minerals help support nutritional intake when dietary consumption is insufficient.\n\n3. Can Palmitoylethanolamide help with nerve pain?\n\nPEA has been investigated in several pain-related and neurological conditions, with clinical research showing promising findings for some pain outcomes. However, it should not automatically be considered a proven treatment for every type of nerve pain or neuropathy.\n\n4. Are Palmitoylethanolamide, Parsley Extract & Multivitamin Tablets safe?\n\nSafety depends on the ingredients, quantities, individual health status, and medicines being used. Most appropriately used basic nutritional supplements are tolerated by many people, but excessive nutrient intake and interactions can occur.\n\n5. What side effects can these tablets cause?\n\nPotential effects can include stomach discomfort, nausea, bowel changes, headache, or sensitivity to an ingredient. The exact side effects depend on the complete formulation.\n\n6. Can these tablets be taken with another multivitamin?\n\nCombining multivitamins should be approached carefully because overlapping ingredients can result in excessive intake of certain vitamins or minerals. Compare both labels before combining supplements.\n\n7. How should I choose palmitoylethanolamide tablets?\n\nCheck the PEA quantity, formulation, parsley extract amount, complete vitamin and mineral profile, serving instructions, manufacturer information, and product quality details.\n\n8. Can these tablets replace prescribed pain medicines?\n\nNo. A nutritional supplement should not automatically replace prescribed medication or professional medical care. Persistent, severe, worsening, or unexplained pain should be evaluated appropriately.\n\n9. Do multivitamins provide long-term health benefits?\n\nMultivitamins can increase nutrient intake when dietary intake is inadequate, but this does not mean they universally prevent chronic diseases or extend lifespan in healthy individuals.\n\n10. Can I take these tablets every day?\n\nFollow the dosage or serving instructions provided for the specific product. Taking more than the recommended amount does not necessarily provide greater benefits and may increase the risk of excessive nutrient intake.\n\nConclusion\n\nPalmitoylethanolamide, Parsley Extract & Multivitamin Tablets** combine **PEA, parsley extract, vitamins, and minerals** into a single nutritional formulation. PEA is the component with the most relevant clinical research, particularly in relation to pain-related outcomes, while parsley contributes naturally occurring botanical compounds and the multivitamin component supports dietary micronutrient intake.\n\nThe benefits and appropriate use of the combination depend on the exact formulation, ingredient quantities, and individual nutritional requirements. Therefore, consumers should review the complete product label and use the supplement according to its recommended directions.",
"price": 579.0,
"discountamount": 170.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2499,
"imageuri": "https://productimages.withfloats.com/actual/6a952f923833cb5247c5da2d.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a952f923833cb5247c5da2d.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-31T07:38:55.369Z",
"updatedon": "2026-08-31T07:38:55.369Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//palmitoylethanolamide-parsley-extract-multivitamin-tablets/2499",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PALMI URIDIN 600",
"category": "NEUROLOGY RANGE",
"tags": [
"Palmitoylethanolamide,Parsley Extract & Multivitamin Tablets",
"palmitoylethanolamide",
"multivitamin tablets",
"best multivitamin tablets",
"multivitamin tablets uses"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a7722af7f45a0190eb37920",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tolperisone Hydrochloride & Paracetamol Tablets",
"description": "TOPERITIME P 150/325: Dual-Action Relief for Musculoskeletal Pain and Spasms\nTOPERITIME P 150/325 is a prescription combination therapy formulated to treat acute musculoskeletal discomfort, muscle stiffness, and associated inflammatory pain. By uniting a centrally acting muscle relaxant with a proven analgesic, this film-coated tablet addresses both the neurological and physical aspects of muscle strain, restoring movement and facilitating recovery.\n\nActive Ingredients\nEach film-coated tablet contains:\n\nTolperisone Hydrochloride (150 mg): A muscle relaxant targeting involuntary contractions within the central nervous system.\n\nParacetamol (325 mg): A widely recognized analgesic and antipyretic agent that blocks pain signal transmission.\n\nAvailable in blister packaging and dispensed strictly under a licensed physician's order.\n\nTherapeutic Mechanism\nPainful muscle conditions often create a feedback loop where localized pain triggers involuntary spasms, which in turn exacerbate the pain. TOPERITIME P 150/325 disrupts this cycle through a two-pronged mechanism:\n\nNeuromuscular Regulation: Tolperisone Hydrochloride acts on the spinal cord and brainstem reflexes to inhibit hyperactive nerve impulses driving muscle tension. Unlike traditional skeletal muscle relaxants, it achieves this with minimal central nervous system depression, significantly reducing the likelihood of heavy sedation.\n\nNociceptive Blocking: Paracetamol inhibits prostaglandin synthesis within the central nervous system, raising the body's overall pain threshold and attenuating pain signals originating from injured tissues.\n\nBy simultaneously relaxing tight muscle fibers and dampening pain sensation, the formulation provides comprehensive symptomatic relief.\n\nClinical Indications\nHealthcare professionals may prescribe TOPERITIME P 150/325 for various acute and subacute conditions characterized by pain and hypertonia, including:\n\nAcute muscle spasms and athletic injuries\n\nAcute or chronic lower back pain (lumbago)\n\nCervical spine discomfort and stiff neck\n\nCervical and lumbar spondylosis\n\nFrozen shoulder (adhesive capsulitis)\n\nPost-operative or post-traumatic muscle recovery\n\nGeneralized connective tissue or orthopedic pain\n\nKey Clinical Features\nBalanced Dual Action: Simultaneously targets involuntary contractions and pain sensation.\n\nLow-Sedation Profile: Tolperisone allows patients to maintain daily function without severe daytime drowsiness typical of older relaxants.\n\nEnhanced Mobility: Reduces joint and tissue stiffness, enabling better engagement in physical rehabilitation.\n\nStreamlined Regimen: Combines two therapeutic agents into a single convenient dosage form.\n\nUsage Guidelines\nThis medication must be taken strictly in accordance with a medical prescription.\n\nAdministration: Swallow the tablet whole with water. Do not crush, chew, or split the film-coated tablet.\n\nTiming: Take immediately after a meal to reduce potential gastrointestinal upset, unless directed otherwise by a doctor.\n\nCompliance: Complete the full course prescribed by your physician, and do not alter the recommended dosage.\n\nPotential Side Effects\nWhile generally well-tolerated, some individuals may experience mild side effects, including:\n\nGastrointestinal distress or mild nausea\n\nTransient dizziness or lightheadedness\n\nHeadaches\n\nGeneral fatigue or muscular weakness\n\nRare: Hypersensitivity reactions or cutaneous skin rashes (discontinue use and consult a physician immediately if severe symptoms appear).\n\nSafety Precautions and Considerations\nConsult a medical practitioner prior to initiating treatment if any of the following apply:\n\nPre-existing hepatic (liver) or renal (kidney) impairment\n\nKnown hypersensitivity to Tolperisone, Paracetamol, or related compounds\n\nPregnancy, plans for pregnancy, or active breastfeeding\n\nHistory of chronic alcohol dependency (due to increased liver sensitivity with Paracetamol)\n\nConcurrent use of other medications, particularly other products containing Paracetamol or central nervous system depressants\n\nStorage and Handling\nStore in a cool, dry area below 25°C (77°F).\n\nProtect from direct light, heat, and moisture.\n\nKeep strictly out of reach of children and pets.\n\nCheck the packaging expiration date before administration.\n\nFrequently Asked Questions\nWhat primary conditions does TOPERITIME P 150/325 treat?\n\nIt is indicated for short-term relief from acute musculoskeletal pain, muscle spasms, neck strains, backaches, and related orthopedic disorders.\n\nWhy is Tolperisone combined with Paracetamol?\n\nTolperisone eases muscle tightness at the neurological level, while Paracetamol lowers overall pain perception, creating a synergistic effect that addresses both spasm and pain together.\n\nWill this medication cause severe drowsiness?\n\nTolperisone is specifically designed to exert less sedating activity compared to older muscle relaxants. However, individual sensitivity varies, so caution is advised when driving or operating machinery until individual tolerance is established.\n\nIs TOPERITIME P 150/325 available over the counter?\n\nNo. It requires a valid medical prescription and direct supervision by a registered healthcare professional.",
"price": 95.0,
"discountamount": 29.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2493,
"imageuri": "https://productimages.withfloats.com/actual/6a7722b0ed25653efa18364e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a7722b0ed25653efa18364e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-08T12:35:59.075Z",
"updatedon": "2026-08-08T12:35:59.075Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-paracetamol-tablets/2493",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TOPERITIME P 150/325",
"category": "ORTHOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a50b1ae8f6638fa60654b85",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Bromfenac Ophthalmic Solution 0.09% w/v",
"description": "Bromfenac ophthalmic solution 0.09% w/v is a prescription non-steroidal anti-inflammatory drug (NSAID) eye drop used primarily to treat pain and inflammation following cataract surgery and to reduce the risk of post-operative cystoid macular edema. Unlike corticosteroid eye drops, bromfenac is not a steroid — it works by inhibiting the cyclooxygenase (COX) enzyme, blocking the production of prostaglandins that drive inflammation, redness, and pain. A key advantage of bromfenac is its once-daily dosing, compared to the multiple daily doses required by many other topical NSAIDs and steroids, which improves ease of use during post-surgical recovery. Common side effects include mild burning or stinging on instillation and temporary blurred vision, while rare but serious risks include corneal complications with prolonged or inappropriate use. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Bromfenac Ophthalmic Solution 0.09% w/v?\nBromfenac ophthalmic solution 0.09% w/v is a topical non-steroidal anti-inflammatory drug (NSAID) formulated for use in the eye. It is most commonly prescribed to manage inflammation and pain following ocular surgery, particularly cataract surgery, and is also used to help reduce the risk of post-operative cystoid macular edema, a swelling of the central retina that can occur after intraocular procedures.\nAs an NSAID, bromfenac differs fundamentally from corticosteroid eye drops. It does not carry the risk of raising intraocular pressure (IOP) that steroids do, making it a valuable option — often used alongside or instead of a steroid — in the post-surgical care protocol, depending on the surgeon's assessment.\nOne of bromfenac's most notable practical advantages is its once-daily dosing schedule, which sets it apart from several other ophthalmic NSAIDs that require two to four applications per day. This simplified regimen can improve patient adherence during the post-operative recovery period.\n\nHow Does Bromfenac Work? (Mechanism of Action)\n\nTissue injury response – Ocular surgery and inflammation trigger the release of arachidonic acid from damaged cell membranes.\nCyclooxygenase (COX) enzyme activity – The COX-1 and COX-2 enzymes convert arachidonic acid into prostaglandins, which are key mediators of inflammation, pain, and vascular permeability.\nCOX inhibition by bromfenac – Bromfenac inhibits both COX-1 and COX-2 enzymes, blocking the prostaglandin synthesis pathway.\nReduced inflammation and pain – With prostaglandin production suppressed, inflammation, redness, and post-surgical discomfort are reduced.\nProtection against macular edema – By limiting prostaglandin-driven vascular permeability, bromfenac also helps lower the risk of fluid accumulation in the macula following surgery.\n\n\nClinical Indications\nIndicationDetailsPost-operative inflammationPrimary use following cataract surgeryPost-operative pain managementReduces surgical site discomfort during recoveryPrevention of post-operative cystoid macular edemaUsed prophylactically around the time of cataract surgeryAdjunct to steroid therapySometimes used alongside corticosteroid drops for comprehensive post-surgical control\n\nDosage & Administration\nParameterRecommendationStandard doseOne drop in the operated eye, once dailyTimingOften started shortly before surgery and continued through the recovery period, as directedDurationTypically a defined post-operative course as prescribed by your ophthalmic surgeonContact lensesAvoid wearing contact lenses during the immediate post-operative period unless advised otherwiseMissed doseApply as soon as remembered; do not double the next doseCombination useMay be prescribed alongside antibiotic and/or steroid eye drops as part of a full post-surgical regimen — space applications as directed\nNote: Always follow your surgeon's specific pre- and post-operative dosing schedule, as timing around the surgery date is clinically important.\n\nKey Benefits\n\nEffectively reduces post-surgical pain and inflammation without the IOP-related risks of steroids\nOnce-daily dosing improves convenience and adherence compared to multi-dose NSAID or steroid regimens\nHelps lower the risk of post-operative cystoid macular edema, a potentially vision-affecting complication\nCan be used alongside steroid and antibiotic eye drops as part of a comprehensive post-surgical protocol\nGenerally does not raise intraocular pressure, unlike corticosteroid alternatives\nSupports a smoother, more comfortable post-operative recovery experience\n\n\nPrecautions\n\nUse strictly as directed by your ophthalmic surgeon, particularly regarding timing before and after surgery\nUse with caution in patients with known bleeding disorders or those taking medications that increase bleeding tendency, as NSAIDs can affect clotting\nRare but serious corneal complications (including delayed healing or, very rarely, corneal thinning) have been reported with prolonged or inappropriate NSAID use — report any unusual eye pain or vision change immediately\nNot recommended for patients with known hypersensitivity to bromfenac or other NSAIDs\nCaution advised in patients with complicated ocular surgeries, pre-existing corneal disease, or dry eye, as these may increase sensitivity to corneal side effects\nAvoid contact lens wear during the treatment period unless specifically advised by your doctor\nInform your doctor of all other eye medications and systemic drugs, especially blood thinners\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nMild burning or stinging sensation on instillation\nTemporary blurred vision\nEye redness\nEye discomfort or itching\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nPersistent or worsening eye pain\nDelayed corneal healing\nRare corneal complications, including corneal thinning or perforation with prolonged/inappropriate use\nIncreased risk of bleeding at the ocular surface in susceptible individuals\nSigns of an allergic reaction (swelling, itching, rash)\n\nDiscontinue and contact your ophthalmologist immediately if any serious or persistent symptom develops.\n\nComparison: Bromfenac vs. Other Post-Surgical Anti-Inflammatory Options\nTreatmentClassDosing FrequencyKey ConsiderationBromfenac ophthalmic solution 0.09%NSAIDOnce dailyConvenient dosing; no IOP risk; rare corneal risk with prolonged usePrednisolone acetateCorticosteroidMultiple times dailyEffective anti-inflammatory; carries IOP and cataract risk with prolonged useKetorolac ophthalmic solutionNSAIDMultiple times dailySimilar NSAID mechanism; more frequent dosing than bromfenacNepafenac ophthalmic suspensionNSAID (prodrug)1–3 times daily depending on formulationAlternative NSAID option; dosing varies by strength\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported reduction in post-operative cystoid macular edema incidence with prophylactic NSAID use[Placeholder – insert verified clinical trial statistic]Typical duration of post-cataract-surgery bromfenac therapy[Placeholder – insert verified reference range]Reported rate of corneal adverse events with appropriate short-course use[Placeholder – insert epidemiological reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Bromfenac Ophthalmic Solution 0.09% w/v\nThe price of bromfenac ophthalmic solution 0.09% w/v varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nBromfenac ophthalmic solution 0.09% w/v has become a widely used part of modern post-cataract-surgery care, offering effective pain and inflammation control along with a meaningful reduction in the risk of post-operative cystoid macular edema — all with the convenience of once-daily dosing. As an NSAID rather than a steroid, it avoids the intraocular pressure concerns associated with corticosteroid therapy, though it carries its own specific precautions, particularly around rare corneal complications with prolonged or inappropriate use. Used exactly as directed by your ophthalmic surgeon, within the prescribed post-operative window, bromfenac supports a smoother, more comfortable surgical recovery.\n\nFrequently Asked Questions\n\n1. What is bromfenac ophthalmic solution 0.09% used for?\nIt is used to treat pain and inflammation following cataract surgery and to help reduce the risk of post-operative cystoid macular edema, a swelling of the central retina that can occur after eye surgery.\n\n2. Is bromfenac a steroid?\nNo. Bromfenac is a non-steroidal anti-inflammatory drug (NSAID). It works by inhibiting the cyclooxygenase (COX) enzyme rather than acting through the steroid pathway, and it does not carry the intraocular pressure risks associated with corticosteroids.\n\n3. How often should bromfenac eye drops be used?\nBromfenac ophthalmic solution 0.09% is typically used once daily in the operated eye, making it more convenient than many other post-surgical eye drops that require multiple daily doses.\n\n4. How long is bromfenac used after cataract surgery?\nThe duration is determined by your ophthalmic surgeon based on your individual recovery, often continuing through a defined post-operative period as part of your overall surgical care protocol.\n\n5. Can bromfenac be used with steroid eye drops?\nYes, bromfenac is often prescribed alongside corticosteroid and/or antibiotic eye drops as part of a comprehensive post-surgical regimen, with applications spaced as directed by your doctor.\n\n6. What are the side effects of bromfenac eye drops?\nCommon side effects include mild burning or stinging upon application, temporary blurred vision, and eye redness. Rare but serious effects can include delayed corneal healing or corneal complications with prolonged or inappropriate use.\n\n7. Does bromfenac raise eye pressure?\nNo, as an NSAID, bromfenac does not typically raise intraocular pressure the way corticosteroid eye drops can, which is one of its key advantages in post-surgical care.\n\n8. Can bromfenac cause corneal problems?\nRare but serious corneal complications, including delayed healing or corneal thinning, have been reported with prolonged or inappropriate NSAID use. Any unusual eye pain or vision change should be reported to your doctor immediately.\n\n9. Is bromfenac safe for people on blood thinners?\nNSAIDs like bromfenac can affect bleeding tendency, so patients on blood-thinning medications or with known bleeding disorders should inform their doctor before starting treatment.\n10. Can contact lenses be worn while using bromfenac?\nIt is generally advised to avoid wearing contact lenses during the post-operative treatment period unless your ophthalmologist specifically advises otherwise.\n11. What happens if I miss a dose of bromfenac?\nApply the missed dose as soon as you remember, unless it is nearly time for your next scheduled dose, in which case skip the missed dose. Do not double up doses.\n12. How is bromfenac different from ketorolac eye drops?\nBoth are NSAIDs with a similar mechanism of action, but bromfenac typically requires only once-daily dosing, while ketorolac usually requires multiple applications per day.\n13. Can bromfenac prevent macular edema after cataract surgery?\nBromfenac is commonly used prophylactically around the time of cataract surgery to help reduce the risk of post-operative cystoid macular edema, a recognized complication of intraocular surgery.\n\n14. Is bromfenac safe for long-term use?\nBromfenac is generally prescribed for a defined post-operative course rather than continuous long-term use, and prolonged or unsupervised use should be avoided due to rare corneal risks.\n\n15. Who should not use bromfenac eye drops?\nPatients with known hypersensitivity to bromfenac or other NSAIDs, or those with certain pre-existing corneal or bleeding conditions, should use bromfenac only under close medical supervision, if at all.\n\n16. Does bromfenac cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.\n\n17. Can bromfenac be used before cataract surgery as well as after?\nYes, bromfenac is often started shortly before surgery and continued through the post-operative recovery period, following the specific schedule set by your ophthalmic surgeon.\n",
"price": 195.0,
"discountamount": 136.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2472,
"imageuri": "https://productimages.withfloats.com/actual/6a50b1b32d7a16f0f95be110.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a50b1b32d7a16f0f95be110.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-10T08:47:42.715Z",
"updatedon": "2026-07-10T08:47:42.715Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//bromfenac-ophthalmic-solution-0-09-w-v/2472",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION BROMAXIS 0.09%",
"category": "Opthalmology Range",
"tags": [
"Bromfenac Ophthalmic Solution 0.09% w/v",
"bromfenac ophthalmic solution 0.09%"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a50a30c9e1ef0fb4df551b0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "dorzolamide eye drops ip",
"description": "Dorzolamide eye drops IP are a prescription ophthalmic solution used to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Dorzolamide belongs to a class of drugs called carbonic anhydrase inhibitors, which work by reducing the production of aqueous humor (the fluid inside the eye), thereby lowering pressure within the eye. It is typically used two to three times daily and begins measurably lowering eye pressure within about 2 hours, though consistent long-term use is essential for sustained control. Common side effects include a temporary bitter or unusual taste in the mouth, burning or stinging on instillation, and blurred vision. Because dorzolamide is chemically a sulfonamide derivative, it should be used cautiously in patients with known sulfa allergies or significant kidney impairment, and only under an ophthalmologist's supervision. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Dorzolamide Eye Drops IP?\nDorzolamide Eye Drops IP is a topical prescription medication used primarily to manage glaucoma and ocular hypertension — conditions characterized by abnormally elevated pressure inside the eye that, if left uncontrolled, can damage the optic nerve and lead to progressive, irreversible vision loss.\nThe “IP” designation indicates the formulation conforms to standards set out in the Indian Pharmacopoeia, ensuring consistent quality, purity, and potency.\nDorzolamide belongs to the carbonic anhydrase inhibitor (CAI) class of anti-glaucoma medications. Unlike oral carbonic anhydrase inhibitors (such as acetazolamide), which act systemically and often cause more pronounced side effects, topical dorzolamide is designed to act locally within the eye, offering effective IOP reduction with comparatively lower systemic exposure — though some systemic absorption can still occur.\nIt is frequently prescribed either as a standalone treatment or in combination with other IOP-lowering agents, such as beta-blockers (e.g., timolol) or prostaglandin analogues, when a single agent does not achieve adequate pressure control.\n\nHow Does Dorzolamide Work? (Mechanism of Action)\n\nAqueous humor production – The ciliary body inside the eye continuously produces aqueous humor, the clear fluid that maintains intraocular pressure and nourishes ocular tissues.\nCarbonic anhydrase enzyme – This enzyme, found in the ciliary body, plays a key role in the chemical reactions that generate bicarbonate ions, which drive fluid secretion into the eye.\nEnzyme inhibition – Dorzolamide inhibits carbonic anhydrase (specifically the II isoenzyme) within the ciliary processes.\nReduced fluid production – With the enzyme inhibited, bicarbonate-dependent fluid transport slows down, resulting in decreased aqueous humor formation.\nLowered intraocular pressure – Less fluid production means less pressure buildup inside the eye, helping protect the optic nerve from pressure-related damage over time.\n\n\nClinical Indications\nIndicationDetailsOpen-angle glaucomaPrimary indication; helps control chronic elevated IOPOcular hypertensionUsed to reduce elevated eye pressure even before glaucoma-related damage occursAdjunct therapyCombined with beta-blockers or prostaglandin analogues when monotherapy is insufficientPost-laser or post-surgical IOP spikesSometimes used short-term under specialist guidance\n\nDosage & Administration\nParameterRecommendationStandard dose (monotherapy)One drop in the affected eye(s), three times dailyStandard dose (with other IOP-lowering drops)Often reduced to twice daily when combined, per doctor's instructionsOnset of actionMeasurable IOP reduction typically begins within about 2 hoursPeak effectGenerally within a few hours of instillationIf using multiple eye dropsSpace different eye medications at least 10 minutes apartMissed doseApply as soon as remembered; skip if near the next scheduled dose — do not double upDuration of useLong-term, ongoing therapy as glaucoma is a chronic condition requiring continuous management\nNote: Consistency is critical — missed doses can allow intraocular pressure to rise, increasing the risk of progressive optic nerve damage.\n\nKey Benefits\n\nEffectively lowers intraocular pressure in both glaucoma and ocular hypertension\nActs locally in the eye, generally producing lower systemic side effects compared to oral carbonic anhydrase inhibitors\nCan be used as monotherapy or in combination with other classes of glaucoma medication for enhanced pressure control\nHelps protect the optic nerve from pressure-related damage with consistent long-term use\nAvailable in a well-established, pharmacopoeia-standardized formulation (IP grade)\nSuitable for long-term, chronic disease management in glaucoma patients\n\n\nPrecautions\n\nUse strictly as prescribed and do not adjust dosing without consulting your ophthalmologist\nInform your doctor if you have a known sulfonamide (sulfa) allergy, since dorzolamide is chemically related to sulfa drugs\nUse with caution in patients with significant kidney (renal) impairment, due to potential for systemic absorption\nNot typically recommended in patients with severe corneal disease without specialist evaluation\nIf using contact lenses, remove before instillation and reinsert only after the interval advised by your doctor\nRegular eye pressure monitoring and follow-up visits are essential during treatment\nInform your doctor of all other eye medications and systemic drugs you are using\nAvoid touching the dropper tip to the eye or any surface to prevent contamination\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nTemporary bitter or unusual taste in the mouth after application\nBurning or stinging sensation on instillation\nBlurred vision immediately after use\nEye redness or itching\nMild eye discomfort\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nSigns of an allergic reaction (rash, swelling, severe itching)\nPersistent eye pain or significant vision changes\nSigns of corneal problems (persistent redness, discharge, sensitivity to light)\nSystemic effects related to sulfonamide sensitivity, in rare cases\n\nIf any serious or persistent symptom occurs, discontinue use and contact your ophthalmologist immediately.\n\nComparison: Dorzolamide vs. Other Anti-Glaucoma Therapies\nTreatmentClassMechanismKey ConsiderationDorzolamide eye dropsCarbonic anhydrase inhibitorReduces aqueous humor productionSulfa-related caution; often used as adjunct therapyTimolol eye dropsBeta-blockerReduces aqueous humor production via a different pathwayCaution in asthma, heart conditionsLatanoprost / prostaglandin analoguesProstaglandin analogueIncreases aqueous humor outflowOnce-daily dosing; may darken iris/eyelash growthBrimonidineAlpha-2 agonistReduces production and increases outflowCan cause drowsiness, dry mouthOral acetazolamideSystemic carbonic anhydrase inhibitorReduces aqueous humor production systemicallyMore pronounced systemic side effects than topical dorzolamide\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueAverage IOP reduction achieved with dorzolamide monotherapy[Placeholder – insert verified clinical trial statistic]Prevalence of open-angle glaucoma in adults over 40[Placeholder – insert epidemiological reference]Proportion of patients requiring combination glaucoma therapy[Placeholder – insert verified reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Dorzolamide Eye Drops IP\nThe price of dorzolamide eye drops IP varies depending on pack size, brand, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nDorzolamide Eye Drops IP play a well-established role in the long-term management of glaucoma and ocular hypertension, offering targeted, localized reduction of intraocular pressure through carbonic anhydrase inhibition. Whether used alone or alongside other classes of IOP-lowering medication, consistent, correctly timed use is essential to protect the optic nerve from progressive, irreversible damage. Because dorzolamide is a sulfonamide derivative with potential for systemic absorption, patients with sulfa allergies or kidney impairment should discuss suitability carefully with their ophthalmologist. As with all glaucoma therapy, regular monitoring and adherence to the prescribed regimen — rather than occasional or as-needed use — are what ultimately safeguard long-term vision.\n\nFrequently Asked Questions\n\n1. What is dorzolamide eye drops used for?\nDorzolamide eye drops are used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, helping protect the optic nerve from pressure-related damage.\n\n2. How long does it take dorzolamide to lower eye pressure?\nDorzolamide typically begins measurably lowering intraocular pressure within about 2 hours of application, though consistent, long-term use is needed to maintain stable pressure control over time.\n\n3. What are the side effects of dorzolamide?\nCommon side effects include a temporary bitter or unusual taste in the mouth, burning or stinging upon application, blurred vision, and mild eye redness or discomfort. Less commonly, allergic reactions or persistent eye irritation can occur and should be reported to a doctor.\n4. Does dorzolamide affect the kidneys?\nDorzolamide is a sulfonamide derivative, and although it is applied topically with generally low systemic absorption, caution is advised in patients with significant kidney impairment. Patients with known kidney disease or sulfa allergies should inform their doctor before starting treatment.\n\n5. How often should dorzolamide eye drops be used?\nDorzolamide is typically used three times daily as monotherapy, or twice daily when combined with other glaucoma medications, exactly as directed by your ophthalmologist.\n\n6. Can dorzolamide be used with other glaucoma eye drops?\nYes, dorzolamide is commonly combined with beta-blockers, prostaglandin analogues, or other IOP-lowering agents when a single medication does not achieve adequate pressure control. Different eye drops should be spaced at least 10 minutes apart.\n\n7. Is dorzolamide safe for long-term use?\nYes, dorzolamide is designed for long-term, ongoing use in chronic glaucoma management, provided it is used under regular ophthalmologist supervision with periodic eye pressure monitoring.\n\n8. Who should not use dorzolamide eye drops?\nPatients with known hypersensitivity to sulfonamides, significant kidney impairment, or specific contraindications identified by their doctor should use dorzolamide only under close medical supervision, if at all.\n\n9. Does dorzolamide cause blurred vision?\nTemporary blurred vision can occur immediately after applying dorzolamide. This is usually short-lived, but if it persists, you should consult your ophthalmologist.\n\n10. Can dorzolamide eye drops be used with contact lenses?\nIt's generally recommended to remove contact lenses before applying dorzolamide and reinsert them only after the interval advised by your doctor, as certain preservatives in eye drops can affect contact lens materials.\n\n11. What happens if I miss a dose of dorzolamide?\nApply the missed dose as soon as you remember, unless it is almost time for your next scheduled dose — in that case, skip the missed dose and continue your regular schedule. Do not double up doses.\n\n12. Why does dorzolamide cause a bitter taste?\nThe bitter taste occurs because a small amount of the eye drop drains through the tear duct into the nasal passage and throat, where it can be tasted. This is a recognized, generally harmless effect of topical carbonic anhydrase inhibitors.\n13. Is dorzolamide the same as timolol eye drops?\nNo. Dorzolamide is a carbonic anhydrase inhibitor, while timolol is a beta-blocker. Both lower eye pressure but through different mechanisms, and they are sometimes prescribed together for enhanced effect.\n\n14. Can dorzolamide be used during pregnancy?\nUse during pregnancy or breastfeeding should only occur under direct medical supervision. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting dorzolamide.\n\n15. How is dorzolamide different from oral glaucoma medications?\nTopical dorzolamide acts locally in the eye and generally causes fewer systemic side effects than oral carbonic anhydrase inhibitors like acetazolamide, which act throughout the body and can cause more pronounced systemic effects.\n16. Can stopping dorzolamide suddenly cause problems?\nStopping dorzolamide abruptly can allow intraocular pressure to rise again, increasing the risk of progressive optic nerve damage. Always consult your ophthalmologist before discontinuing treatment.\n\n17. Does dorzolamide need to be refrigerated?\nStorage requirements can vary by brand and formulation; always follow the storage instructions printed on your specific product's packaging or as advised by your pharmacist.",
"price": 350.0,
"discountamount": 105.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2470,
"imageuri": "https://productimages.withfloats.com/actual/6a50a30e9569e07de66607f4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a50a30e9569e07de66607f4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-10T07:45:16.262Z",
"updatedon": "2026-07-10T07:45:16.262Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//dorzolamide-eye-drops-ip/2470",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION DORZONIX 2%",
"category": "Opthalmology Range",
"tags": [
"dorzolamide eye drops ip",
"dorzolamide eye drops",
"dorzolamide eye drops uses",
"dorzolamide eye drops uses in hindi",
"dorzolamide eye drops price",
"dorzolamide eye drops ip",
"dorzolamide eye drops brand name",
"dorzolamide eye drops brands"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a4cf32ff4503514c0b03999",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "tropicamide eye drops ip",
"description": "Tropicamide eye drops IP are a prescription ophthalmic solution used to dilate the pupil (mydriasis) and temporarily paralyze the eye's focusing muscles (cycloplegia) before eye examinations and certain ocular procedures. Dilation typically begins within 20–40 minutes of application and lasts around 4–6 hours, though effects can occasionally persist longer. Tropicamide is widely used by ophthalmologists and optometrists to get a clear, detailed view of the retina, optic nerve, and back of the eye — something that isn't possible through an undilated pupil. It's generally well tolerated, though temporary blurred vision and light sensitivity are expected effects rather than side effects to worry about.\nWhat Is Tropicamide Eye Drops IP?\nTropicamide eye drops IP (manufactured to Indian Pharmacopoeia standards) are an anticholinergic (antimuscarinic) ophthalmic solution, commonly available in 0.5% and 1% strengths. “IP” indicates the formulation meets the quality and purity standards set by the Indian Pharmacopoeia.\nTropicamide belongs to the same broad drug family as atropine but has a much shorter duration of action, which is precisely why it's the preferred choice for routine eye examinations — it does its job quickly and wears off within hours rather than days. It's typically administered directly by a healthcare provider in a clinical or hospital setting, rather than self-administered at home.\nHow Tropicamide Works (Mechanism of Action)\n\nMuscarinic receptor blockade — Tropicamide blocks acetylcholine from binding to muscarinic receptors in the eye's iris sphincter and ciliary muscles.\nPupil dilation (mydriasis) — With the sphincter muscle relaxed, the pupil's natural constricting reflex is blocked, allowing it to widen.\nParalysis of accommodation (cycloplegia) — The ciliary muscle, responsible for adjusting eye focus for near vision, is also relaxed, temporarily reducing the eye's ability to focus on close objects.\nClear visualization of the fundus — With the pupil fully dilated, the examining doctor can clearly view the retina, macula, optic nerve, and vitreous — structures that are otherwise obscured behind an undilated pupil.\nNatural wearing-off — As the drug is metabolized and clears from the eye tissue, muscle tone gradually returns, and the pupil returns to its normal size and reactivity.\n\nClinical Indications\nUse CaseWhy Tropicamide Is UsedDilated fundus examinationAllows a detailed view of the retina, optic nerve, and maculaPre- and post-cataract surgeryAchieves adequate pupil dilation for surgical visibility and reduces post-operative inflammation-related discomfortDiagnosis of refractive errors in childrenCycloplegic effect prevents the eye from actively focusing, giving a more accurate refraction measurementRetinal and posterior segment proceduresSupports clear visualization for laser treatments and retinal surgeryEvaluation of optic nerve or cranial nerve abnormalitiesHelps assess disc swelling, cup-to-disc ratio, and pupillary responsesAnterior uveitis management (adjunctive use)Cycloplegic effect can reduce pain and the risk of complications like posterior synechiae\nDosage Guidelines\nParameterTypical GuidanceStandard strength0.5% or 1% ophthalmic solutionTypical doseOne drop instilled into the eye(s), as directed by the examining doctorOnset of actionDilation usually begins within 20–40 minutesDuration of effectCommonly 4–6 hours; can occasionally last longer depending on individual responseAdministration techniqueTilt the head back, pull down the lower eyelid, instill the drop, then close the eye gently for 2–3 minutes without blinking; applying gentle pressure at the inner corner of the eye can help limit systemic absorptionRepeat dosingA second drop may be used after several minutes if dilation is insufficient, at the doctor's discretion\nTropicamide is typically administered by a healthcare professional in a clinical setting rather than self-instilled at home, and dosing should always follow the specific instructions of the treating doctor.\nKey Benefits\n\nProvides fast, reliable pupil dilation, enabling a thorough examination of the back of the eye\nShort duration of action (compared to atropine) means vision and eye function return to normal within hours, not days\nWell-established, widely used mydriatic with a strong long-term safety record in clinical practice\nSupports more accurate diagnosis of refractive errors in children through its cycloplegic effect\nUseful both for routine diagnostic eye exams and as part of pre-/post-surgical eye care\nAvailable in two strengths (0.5% and 1%), allowing the examining doctor to tailor the degree of dilation needed\n\nPrecautions\n\nShould only be administered by, or under the direct guidance of, a qualified eye care professional\nWear sunglasses after application, since dilated pupils let in significantly more light and cause noticeable light sensitivity\nAvoid driving or operating machinery until vision returns to normal, as focusing on nearby objects (like a dashboard or phone) will be impaired\nDo not wear contact lenses during instillation, as the preservative in some formulations can discolor soft lenses\nUse caution in patients with a history of narrow-angle glaucoma, as pupil dilation can rarely trigger a sudden, serious rise in eye pressure (angle-closure glaucoma)\nIn children, wash hands thoroughly after administration, since rare but serious anticholinergic effects (including psychosis) have been reported, particularly with higher doses or accidental ingestion\nInform the doctor of any history of heart conditions, as anticholinergic effects can occasionally affect heart rate\n\nSide Effects\nCommon side effects (expected and temporary):\n\nBlurred vision, especially for near objects\nIncreased sensitivity to light (photophobia)\nMild stinging or burning sensation on application\nTransient increase in intraocular pressure\n\nLess common side effects:\n\nDry mouth\nHeadache\nIncreased heart rate\nFlushing or mild fever\nEye surface irritation\n\nRare but serious side effects — seek immediate medical attention:\n\nSigns of an allergic reaction: hives, difficulty breathing, swelling of the face, lips, tongue, or throat\nConfusion, slurred speech, agitation, or hallucinations (rare anticholinergic toxicity, more often reported in children)\nSudden eye pain, severe headache, nausea, or vomiting (possible signs of angle-closure glaucoma)\n\nMost side effects resolve on their own as the drug wears off within a few hours; however, any signs of a serious reaction should be reported to a doctor right away.\nComparison with Alternatives\nFeatureTropicamideAtropineOnset of action20–40 minutes30–40 minutesDuration of effect4–6 hours (short-acting)Up to 1–2 weeks (long-acting)Common useRoutine diagnostic dilation, fundus examsCycloplegic refraction in select cases, anterior uveitis managementPreferred settingOutpatient eye exams, same-day proceduresCases needing prolonged cycloplegia\nTropicamide's shorter duration makes it the preferred first choice for most routine eye examinations, where rapid return to normal vision is desirable.\nKey Statistics\n[Placeholder — pending clinical/regulatory team verification. Do not publish without confirmed source citation for dilation success rates, comparative onset/duration data, or incidence rates of rare adverse effects.]\nExpert Insight\n[Placeholder — reserved for a quote from a qualified ophthalmologist or clinical reviewer. Do not publish without a verified, attributable expert quote.]\nFrequently Asked Questions\n1. What is tropicamide eye drops used for?\nTropicamide eye drops are used to dilate the pupil and temporarily relax the eye's focusing muscles, allowing an eye doctor to clearly examine the retina, optic nerve, and back of the eye during routine eye exams and certain procedures.\n2. How long does dilation last with tropicamide?\nDilation typically begins within 20–40 minutes and lasts about 4–6 hours, though this can vary slightly from person to person. Vision usually returns to normal well within the same day.\n3. What are the risks of tropicamide eye drops?\nCommon effects include temporary blurred vision and light sensitivity. Less commonly, dry mouth, headache, or a faster heartbeat can occur. Rare but serious risks include an allergic reaction or, in susceptible individuals, a sudden rise in eye pressure (angle-closure glaucoma) — these require immediate medical attention.\n4. What are the benefits of tropicamide?\nTropicamide allows for fast, reliable pupil dilation with a much shorter recovery time than older agents like atropine, enabling accurate diagnosis of retinal and optic nerve conditions while letting patients return to normal vision within hours.\nConclusion\nTropicamide eye drops IP remain one of the most widely used and trusted tools in modern eye care, offering fast-acting, short-duration pupil dilation that allows eye care professionals to thoroughly examine the structures at the back of the eye. Its short window of action compared to older cycloplegic agents like atropine makes it especially well suited for routine diagnostic exams, where patients need their vision to return to normal within the same day. While temporary blurred vision and light sensitivity are expected parts of the experience, tropicamide has a strong long-term safety record when administered appropriately by a qualified eye care professional. As with any prescription ophthalmic agent, it should only be used under medical supervision, with simple precautions like wearing sunglasses afterward and avoiding driving until vision normalizes.\n\nDisclaimer: This content is for informational purposes only and is not a substitute for professional medical advice. Tropicamide eye drops IP are a prescription medicine and should only be administered by, or under the direct guidance of, a qualified eye care professional.\nManufactured by:\nSteris Healthcare Pvt. Ltd.\nWHO-GMP & ISO Certified Pharmaceutical Manufacturer\nEmail: contact@sterispharma.com | info@sterispharma.com\nContent last reviewed: July 2026",
"price": 50.0,
"discountamount": 15.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2466,
"imageuri": "https://productimages.withfloats.com/actual/6a4cf331dd4ec8cc0aa1b9e4.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a4cf331dd4ec8cc0aa1b9e4.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-07T12:38:07.8Z",
"updatedon": "2026-07-07T12:38:07.8Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tropicamide-eye-drops-ip/2466",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION TRACOPA 1%",
"category": "Opthalmology Range",
"tags": [
"tropicamide eye drops ip",
"tropicamide eye drops ip uses in hindi",
"tropicamide eye drops",
"tropicamide eye drops uses",
"tropicamide eye drops uses in hindi",
"tropicamide eye drops price",
"tropicamide eye drops bottle",
"tropicamide eye drops side effects",
"tropicamide eye drops brand name"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a266dd8a533ee2656d39b34",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Latanoprost Opthalmic Solution",
"description": "Latanoprost Ophthalmic Solution – Trusted Eye Drop Treatment for Glaucoma and Ocular Hypertension\nLatanoprost Ophthalmic Solution\n\nIf you are looking for an effective treatment to lower elevated eye pressure and protect your vision, Latanoprost Ophthalmic Solution is one of the most widely prescribed medications for glaucoma and ocular hypertension. Known for its proven efficacy, convenient once-daily dosing, and long-term benefits, Latanoprost helps reduce intraocular pressure (IOP), which is a major risk factor for optic nerve damage and vision loss.\n\nMillions of patients worldwide rely on Latanoprost Ophthalmic Solution to manage chronic eye conditions that can gradually affect eyesight. By improving the natural drainage of fluid from the eye, this medication helps maintain healthy eye pressure levels and supports long-term ocular health.\n\nWhether you have recently been diagnosed with glaucoma or are searching for a reliable eye pressure-lowering treatment, this comprehensive guide will help you understand the uses, benefits, mechanism of action, dosage, side effects, and key advantages of Latanoprost Ophthalmic Solution.\n\nWhat Is Latanoprost Ophthalmic Solution?\n\nLatanoprost Ophthalmic Solution is a prescription eye medication belonging to a class of drugs known as prostaglandin analogs. It is primarily used to reduce elevated intraocular pressure in patients with:\n\nOpen-angle glaucoma\nOcular hypertension\nChronic eye pressure management\nRisk of glaucoma progression\n\nElevated pressure inside the eye can damage the optic nerve over time, leading to permanent vision impairment. Latanoprost Ophthalmic Solution helps prevent this damage by facilitating better fluid drainage from the eye.\n\nBecause of its strong effectiveness and convenient dosing schedule, ophthalmologists often recommend Latanoprost as a first-line treatment for glaucoma management.\n\nHow Latanoprost Ophthalmic Solution Works\n\nThe eye continuously produces a fluid known as aqueous humor. This fluid nourishes the eye and helps maintain its shape. Normally, the fluid drains naturally through specialized pathways.\n\nIn glaucoma and ocular hypertension, fluid drainage becomes inadequate, causing pressure to build up inside the eye.\n\nMechanism of Action\n\nLatanoprost works by:\n\nIncreasing the outflow of aqueous humor from the eye\nEnhancing natural fluid drainage through the uveoscleral pathway\nReducing intraocular pressure effectively\nMaintaining healthier pressure levels throughout the day\n\nBy lowering eye pressure, Latanoprost helps reduce stress on the optic nerve and decreases the risk of progressive vision loss.\n\nIts pressure-lowering effect typically lasts for 24 hours, making once-daily administration highly effective for most patients.\n\nUses of Latanoprost Ophthalmic Solution\n1. Open-Angle Glaucoma\n\nOpen-angle glaucoma is the most common form of glaucoma worldwide. Latanoprost helps lower eye pressure and slow the progression of optic nerve damage.\n\n2. Ocular Hypertension\n\nPatients with elevated intraocular pressure but no significant optic nerve damage can benefit from early pressure reduction to prevent glaucoma development.\n\n3. Long-Term Eye Pressure Control\n\nLatanoprost is commonly prescribed for ongoing management of chronic eye conditions requiring consistent pressure regulation.\n\n4. Vision Preservation\n\nBy reducing pressure within the eye, Latanoprost helps protect vision and maintain overall eye health over time.\n\n5. Prevention of Glaucoma Progression\n\nMaintaining controlled intraocular pressure significantly lowers the likelihood of disease advancement and associated vision loss.\n\nKey Benefits of Latanoprost Ophthalmic Solution\nEffective Intraocular Pressure Reduction\n\nLatanoprost is highly effective in lowering elevated eye pressure and maintaining stable control.\n\nOnce-Daily Dosing\n\nThe medication typically requires only one application per day, making treatment simple and convenient.\n\nLong-Lasting Action\n\nA single dose can provide pressure-lowering effects for up to 24 hours.\n\nSupports Optic Nerve Protection\n\nReducing eye pressure helps safeguard the optic nerve from long-term damage.\n\nImproved Treatment Compliance\n\nThe easy dosing schedule encourages consistent medication use and better treatment outcomes.\n\nWidely Trusted by Eye Specialists\n\nLatanoprost has been extensively studied and remains one of the most prescribed glaucoma medications globally.\n\nHelps Preserve Vision\n\nRegular use contributes to long-term visual health and reduces the risk of glaucoma-related blindness.\n\nWho Can Benefit from Latanoprost Ophthalmic Solution?\n\nLatanoprost Ophthalmic Solution may be suitable for:\n\nAdults diagnosed with open-angle glaucoma\nPatients with ocular hypertension\nIndividuals requiring long-term eye pressure management\nPatients seeking convenient once-daily therapy\nIndividuals at risk of optic nerve damage\nPatients requiring preventive glaucoma treatment\n\nYour ophthalmologist will determine whether Latanoprost is appropriate based on your eye condition and medical history.\n\nWhy Buyers Choose Latanoprost Ophthalmic Solution\n\nWhen purchasing glaucoma medication, patients prioritize effectiveness, convenience, and safety. Latanoprost Ophthalmic Solution consistently meets these expectations.\n\nBuyer Intent Advantages\nProven glaucoma treatment\nTrusted by ophthalmologists worldwide\nConvenient once-daily application\nEffective pressure reduction\nLong-term vision protection\nEasy incorporation into daily routines\nSuitable for chronic use\nClinically established safety profile\n\nThese advantages make Latanoprost Ophthalmic Solution one of the most preferred choices for glaucoma management.\n\nHow to Use Latanoprost Ophthalmic Solution\n\nFor best results, use the medication exactly as prescribed by your healthcare provider.\n\nGeneral Directions\nWash your hands thoroughly.\nShake the bottle if instructed.\nTilt your head backward.\nPull down the lower eyelid gently.\nInstill one drop into the affected eye.\nClose your eyes for one to two minutes.\nAvoid touching the dropper tip to any surface.\nReplace the cap securely after use.\n\nLatanoprost is usually administered once daily in the evening unless otherwise directed by your ophthalmologist.\n\nImportant Precautions\n\nBefore using Latanoprost Ophthalmic Solution, inform your healthcare provider if you have:\n\nEye inflammation\nEye infections\nHistory of eye surgery\nMacular edema\nContact lens use\nSevere allergies\nOther ongoing eye conditions\n\nRegular eye examinations are important to monitor treatment effectiveness and eye health.\n\nPossible Side Effects of Latanoprost Ophthalmic Solution\n\nLike all medications, Latanoprost may cause side effects in some individuals.\n\nCommon Side Effects\nEye redness\nMild irritation\nBurning sensation\nItching\nTemporary blurred vision\nIncreased tearing\nDry eye sensation\nLong-Term Cosmetic Changes\n\nSome users may experience:\n\nDarkening of the iris color\nIncreased eyelash growth\nThickening of eyelashes\nDarkening of eyelid skin\n\nThese changes usually occur gradually and may become permanent with prolonged use.\n\nLess Common Side Effects\nEye pain\nSensitivity to light\nSwelling around the eye\nVision disturbances\n\nSeek immediate medical attention if severe allergic reactions or significant vision changes occur.\n\nStorage Instructions\n\nProper storage helps maintain medication quality and effectiveness.\n\nRecommended Storage Guidelines\nStore at the temperature recommended on the product label.\nKeep away from direct sunlight.\nProtect from excessive heat.\nKeep the bottle tightly closed when not in use.\nDo not use after the expiration date.\nKeep out of reach of children.\n\nAlways follow manufacturer-specific storage instructions.\n\nFrequently Asked Questions\nCan Latanoprost cure glaucoma?\n\nNo. Latanoprost does not cure glaucoma but helps control eye pressure and slow disease progression.\n\nHow quickly does it lower eye pressure?\n\nPressure reduction typically begins within a few hours of administration, with maximum effects developing over continued use.\n\nCan it be used long term?\n\nYes. Latanoprost is commonly prescribed for long-term management of glaucoma and ocular hypertension.\n\nWhat happens if I miss a dose?\n\nTake the next scheduled dose as directed. Do not use extra drops to compensate for a missed application.\n\nCan contact lens users use Latanoprost?\n\nYes, but contact lenses may need to be removed before application and reinserted after the recommended waiting period advised by your doctor.\n\nConclusion\n\nLatanoprost Ophthalmic Solution is a highly effective and widely trusted treatment for reducing elevated intraocular pressure associated with glaucoma and ocular hypertension. By enhancing the natural drainage of fluid from the eye, it helps maintain healthy eye pressure levels, protect the optic nerve, and preserve long-term vision.\n\nIts once-daily dosing, proven clinical effectiveness, and established safety profile make it a preferred choice among ophthalmologists and patients alike. Whether you are newly diagnosed with glaucoma or seeking reliable long-term eye pressure management, Latanoprost Ophthalmic Solution offers a dependable solution for protecting your eyesight and supporting overall ocular health.",
"price": 390.0,
"discountamount": 117.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2442,
"imageuri": "https://productimages.withfloats.com/actual/6a266ddeac30b85f9a4b1407.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a266ddeac30b85f9a4b1407.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-06-08T07:23:04.74Z",
"updatedon": "2026-06-08T07:23:04.74Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//latanoprost-opthalmic-solution/2442",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION LOPESTAL",
"category": "Opthalmology Range",
"tags": [
"latanoprost opthalmic solution",
"latanoprost opthalmic",
"latanoprost ophthalmic solution 0.005",
"latanoprost ophthalmic solution 0.005 price",
"latanoprost 0.005 eye drops price in india",
"latanoprost 0.005 eye drops price",
"latanoprost ophthalmic solution uses",
"latanoprost ophthalmic solution uses",
"Latanoprost Opthalmic Solution in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}